Coherus Oncology
CHRS
CHRS
146 hedge funds and large institutions have $1.47B invested in Coherus Oncology in 2019 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 47 increasing their positions, 40 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
25% more funds holding
Funds holding: 117 → 146 (+29)
18% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 40
2.97% less ownership
Funds ownership: 99.29% → 96.32% (-3%)
Holders
146
Holding in Top 10
2
Calls
$8.59M
Puts
$1.08M
Top Buyers
| 1 | +$53.4M | |
| 2 | +$37.1M | |
| 3 | +$26.7M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$25.7M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$16.9M |
Top Sellers
| 1 | -$44.4M | |
| 2 | -$42.9M | |
| 3 | -$17.6M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$17.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$16.7M |